COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Reduce Lap HF

Purpose of Study

To evaluate the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with the LV ejection fraction of > 40%, and elevated left-sided filling pressures.

Trial Status

In follow up

Eligibility Criteria

NYHA classification II – IV, 40 years or older, LV ejection fraction of > 40% within past 6 months, 1 heart failure hospital admission within the past 12 months.

Duration of Participation

Approximately 5 years

Contact Name: Megan Murphy, RN

Contact Phone: 515-235-5089

Contact Email: memurphy@iowaheart.com